Ciclesonide inhaler for post-acute COVID-19 syndrome: promising clinical evidence. Pharm Pract (Granada) [Internet]. 2024 Dec. 18 [cited 2025 Nov. 16];22(3). Available from: https://pharmacypractice.org/index.php/pp/article/view/2990